Literature DB >> 9666258

The effects of interaction between morphine and interleukin-1 on the immune response.

S L Chang1, G D Wu, N A Patel, E L Vidal, M Fiala.   

Abstract

The findings presented here clearly indicate an association between opioid- and cytokine-dependent systems. Exposure to exogenous opioids can produce profound effects on IL-1-mediated immune responses. Chronic exposure to morphine appears to disrupt the brain-immune axis by desensitizing the IL-1 activation of the HPA axis, and consequently potentiate the LEA response to IL-1. On the other hand, endogeneous IL-1, secreted in response to disease or stress, may alter the endogenous opioid pathway by inducing the expression of opioid receptors in endothelial cells. Clinically, the potential impact on the body's defense mechanisms resulting from the interaction between opioids, such as morphine, and cytokines, such as IL-1, can be substantial. Further investigation of this interaction is essential to understanding the extent of damage in human body caused by drugs of abuse, such as morphine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666258     DOI: 10.1007/978-1-4615-5347-2_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

Review 1.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

2.  A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systems.

Authors:  Erik F Langsdorf; Xin Mao; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2011-06-17       Impact factor: 3.478

Review 3.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

4.  Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

Authors:  Nazira El-Hage; Julie A Gurwell; Indrapal N Singh; Pamela E Knapp; Avindra Nath; Kurt F Hauser
Journal:  Glia       Date:  2005-04-15       Impact factor: 7.452

Review 5.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

6.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

7.  Lipopolysaccharide-induced pro-inflammatory cytokines in the brain of rats in the morphine-tolerant state.

Authors:  Linda Staikos; Lorenc Malellari; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-27       Impact factor: 4.147

8.  Interleukin-1 beta-induced up-regulation of opioid receptors in the untreated and morphine-desensitized U87 MG human astrocytoma cells.

Authors:  Linda Staikos Byrne; Jinsong Peng; Sraboni Sarkar; Sulie L Chang
Journal:  J Neuroinflammation       Date:  2012-11-20       Impact factor: 8.322

9.  Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.

Authors:  Masami Suzuki; Nazira El-Hage; Shiping Zou; Yun-Kyung Hahn; Mary E Sorrell; Jamie L Sturgill; Daniel H Conrad; Pamela E Knapp; Kurt F Hauser
Journal:  Mol Neurodegener       Date:  2011-11-17       Impact factor: 14.195

10.  Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.

Authors:  R Chavez-Valdez; L Kovell; R Ahlawat; G L McLemore; M Wills-Karp; E B Gauda
Journal:  J Perinatol       Date:  2012-10-04       Impact factor: 2.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.